ARID1A Regulates Progesterone Receptor Expression in Endometrial Carcinoma and xAtypical Hyperplasia

被引:0
|
作者
Liu, Ying [1 ]
Asaka, Shiho [2 ]
Wang, Tian-Li [1 ]
Shih, Ie-Ming [3 ]
机构
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Shinshu Univ, Sch Med, Matsumoto, Nagano, Japan
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
733
引用
收藏
页码:790 / 790
页数:1
相关论文
共 50 条
  • [21] Histopathologic Correlation with ARID1A Immunohistochemistry in Endometrial Carcinomas, Including Description of Subclonal ARID1A Loss
    Xiong, Jessie
    Smith, Lynelle
    Black, Margaret
    Wolsky, Rebecca
    Post, Miriam
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1270 - S1271
  • [22] Estrogen-α and progesterone receptor expression in cystic endometrial hyperplasia and pyometra in the bitch
    De Bosschere, H
    Ducatelle, R
    Vermeirsch, H
    Simoens, P
    Coryn, M
    ANIMAL REPRODUCTION SCIENCE, 2002, 70 (3-4) : 251 - 259
  • [23] CRISPR/Cas9-Mediated Gene Knockout of ARID1A Promotes Primary Progesterone Resistance by Downregulating Progesterone Receptor B in Endometrial Cancer Cells
    Wang, Haizhen
    Tang, Zhenghua
    Li, Ting
    Liu, Menglu
    Li, Yong
    Xing, Baoling
    ONCOLOGY RESEARCH, 2019, 27 (09) : 1051 - 1060
  • [24] Diagnostic Importance of PAX2, ARID1A, and FOXA1 Biomarkers in Atypical Endometrial Hyperplasia
    Yildiz, Ozlem Nur
    Topal, Cumhur Selcuk
    Zemheri, Itir Ebru
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (08): : 847 - 851
  • [25] ARID1A expression in ovarian clear cell carcinoma with an adenofibromatous component
    Nishikimi, Kyoko
    Kiyokawa, Takako
    Tate, Shinichi
    Iwamoto, Masami
    Shozu, Makio
    HISTOPATHOLOGY, 2015, 67 (06) : 866 - 871
  • [26] ANALYSIS OF PTEN, ESTROGEN RECEPTOR α AND PROGESTERONE RECEPTOR EXPRESSION IN ENDOMETRIAL HYPERPLASIA USING TISSUE MICROARRAY
    Pieczynska, Beata
    Wojtylak, Szymon
    Zawrocki, Anton
    Biernat, Wojciech
    POLISH JOURNAL OF PATHOLOGY, 2011, 62 (03) : 133 - 138
  • [27] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    LABORATORY INVESTIGATION, 2012, 92 : 269A - 269A
  • [28] Loss of BAF250a (ARID1A) Expression in Endometrial Clear Cell Carcinoma: Assessment of Frequency and Clinicopathologic Implications
    Fadare, O.
    Renshaw, I. L.
    Liang, S. X.
    MODERN PATHOLOGY, 2012, 25 : 269A - 269A
  • [29] ARID1A gene mutation in ovarian and endometrial cancers
    Takeda, Takashi
    Banno, Kouji
    Okawa, Ryuichiro
    Yanokura, Megumi
    Iijima, Moito
    Irie-Kunitomi, Haruko
    Nakamura, Kanako
    Iida, Miho
    Adachi, Masataka
    Umene, Kiyoko
    Nogami, Yuya
    Masuda, Kenta
    Kobayashi, Yusuke
    Tominaga, Eiichiro
    Aoki, Daisuke
    ONCOLOGY REPORTS, 2016, 35 (02) : 607 - 613
  • [30] Decreased expression of ARID1A invasively downregulates the expression of ribosomal proteins in hepatocellular carcinoma
    Zhao, Jing
    Xu, Weiran
    Zhang, Yu
    Lv, Xiaomin
    Chen, Yiran
    Ju, Gaoda
    Yang, Fang
    Lin, Li
    Rao, Xiaosong
    Guo, Ziwei
    Xing, Tao
    Li, Li
    Liang, Jun
    BIOMARKERS IN MEDICINE, 2021, 15 (07) : 497 - 508